Learn how Middle Branch Partners helped facilitate three major transactions in 2022 for clients including UFP Technologies, Acrotec Group, MycoScience, and Ethide Laboratories.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.

Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.

There is no question that there is larger distance between European markets today and anytime in recent memory. This had begun before Covid-19 with protectionist trade policies and then continued up to today, as travel restrictions and limitations on visits and shut down much M/A activity, both in Europe and North America. To understand this in greater detail, Chuck Weikel discussed with Göran Brorsson, our European Partner at Middle Branch Partners, about what he is experiencing in the European market.